Search Results 351-360 of 17471 for Metformin

1. Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype - Mayo Clinic

   - Use of anti-obesity medications upon screening (i.e., orlistat, phentermine-topiramate, liraglutide, semaglutide, bupropion-naltrexone), metformin or GLP-1 ...

2. Drugs and Supplements that Start with P - Mayo Clinic

   Pioglitazone (oral route) · Pioglitazone and glimepiride (oral route) · Pioglitazone and metformin (oral route) · Piperacillin and tazobactam (intravenous route).

3. A Study Of Effects Of Semaglutide And Tirzepatide On Gastric Emptying Of Solids In Obesity - Mayo Clinic

   ... metformin, acarbose or DPP-4 inhibitors (e.g. sitagliptin and vildagliptin). Past or current history of pancreatitis, gallstones, history of alcoholism ...

4. Tolazamide (oral route) - Side effects & dosage - Mayo Clinic

   Metformin. Show More. Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be ...

5. Ranolazine For Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) - Mayo Clinic

   ... metformin dose and maintain glycemic control); Previous treatment with ranolazine for > 7 consecutive days within 30 days prior to Randomization, or known ...

6. The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas

   Participation eligibility · Concurrent use of any non-insulin glucose-lowering agent other than metformin (including GLP-1 agonists, Symlin, DPP-4 inhibitors, ...

7. Delafloxacin (intravenous route) - Side effects & uses - Mayo Clinic

   Insulin Glulisine; Insulin Lispro, Recombinant; Linagliptin; Liraglutide; Lixisenatide; Magnesium Sulfate; Metformin; Miglitol; Nateglinide; Pioglitazone ...

8. A Study to Evaluate Response Markers to Treat Rheumatoid Arthritis - Mayo Clinic

   No exposure to metformin; Prednisone dose > 15mg per day within 7 days of blood draw. Participating Mayo Clinic locations. Study statuses change often. Please ...

9. Marina R. Walther-Antonio, Ph.D. - Mayo Clinic Faculty Profiles

   Walther-Antonio is studying the microbiome impact in ovarian cancer recurrence with and without adjuvant metformin treatment in a clinical trial and patient- ...

10. Islet GLP-1 in Prediabetes - Clinical Trials

    Use of any glucose-lowering agents including metformin or sulfonylureas. For female subjects: positive pregnancy test at the time of enrollment or study ...